Target
Pro-glucagon
Ligand
BDBM100827
Substrate
n/a
Meas. Tech.
Glucagon SPA Assay
pH
7.4±0
Ki
20.2±0.0 nM
Citation
 Aspnes, GEDidiuk, MTFilipski, KJGuzman-Perez, ALee, ECPfefferkorn, JAStevens, BDTu, MM Glucagon receptor modulators US Patent  US8507533 Publication Date 8/13/2013 
Target
Name:
Pro-glucagon
Synonyms:
GCG | GLUC_HUMAN | Glucagon | Glucagon receptor (GCGR)
Type:
Enzyme
Mol. Mass.:
20907.95
Organism:
Homo sapiens (Human)
Description:
P01275
Residue:
180
Sequence:
MKSIYFVAGLFVMLVQGSWQRSLQDTEEKSRSFSASQADPLSDPDQMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIAKRHDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGRRDFPEEVAIVEELGRRHADGSFSDEMNTILDNLAARDFINWLIQTKITDRK
  
Inhibitor
Name:
BDBM100827
Synonyms:
US8507533, 138 | US8507533, 151 | US8507533, 374
Type:
Small organic molecule
Emp. Form.:
C27H28F3N3O4
Mol. Mass.:
515.5241
SMILES:
Cc1cc(OC(C2CCC2)c2ccc(cc2)C(=O)NCCC(O)=O)cc(C)c1-n1cc(cn1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: